Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Breast Cancer Health Center

Font Size

Drug Combo Wipes Out Tumor Cells

Herceptin-Tykerb Combo Helps Before Surgery for Early Breast Cancer
WebMD Health News
Reviewed by Laura J. Martin, MD

Dec. 10, 2010 (San Antonio) -- Giving a combination of the targeted drugs Herceptin and Tykerb before breast cancer surgery wipes out tumor cells in about twice as many women as either drug alone.

Both drugs target a protein called HER2 that is overproduced in about 25% of breast cancers. Herceptin blocks the protein on the surface of the cell and Tykerb works inside the cell.

In the study, about 450 women getting chemotherapy were given Herceptin, Tykerb, or a combination of the two.

Tumor cells were eradicated in 51% of women given both drugs, compared with 30% of those given Herceptin alone and 25% of those given Tykerb alone.

The one-two punch has already been shown to extend the lives of women with advanced breast cancer when given after surgery.

The new approach, which involves giving women with early breast cancer the drugs before surgery, holds the possibility of "enhancing the number of women cured and sparing women from [costly] therapies down the road," said study head Jose Baselga, MD, PhD, chief of the division of hematology and oncology and associate director of the Massachusetts General Hospital Cancer Center in Boston.

The women in the current study haven’t been followed for long enough to prove the combo extends lives. But studies in which Herceptin is given after surgery show that 88% of women with HER2-positive breast cancer are alive and free of cancer five years after treatment, he tells WebMD.

Based on the current findings, you would expect giving the combination of Herceptin and Tykerb before surgery and giving Herceptin after surgery would increase that figure to about 90%, Baselga says.

1 | 2 | 3

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
Breast Cancer Treatments Improving
Resolved To Quit Smoking
Woman getting mammogram
Screening Tests for Women
ovarian cancer overview slideshow
serious woman
what is your cancer risk
10 Ways to Revitalize Slideshow